Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Case and Commentary Nov 2016 Should Mental Health Screening and Psychotherapy Be Required Prior to Body Modification for Gender Expression? Timothy F. Murphy, PhD Although patients’ medical gender transition can be facilitated by counseling, as a matter of medical ethics, informed consent must be obtained for treatment. AMA J Ethics. 2016;18(11):1079-1085. doi: 10.1001/journalofethics.2016.18.11.ecas2-1611. Case and Commentary Nov 2016 Should Psychiatrists Prescribe Gender-Affirming Hormone Therapy to Transgender Adolescents? Cary S. Crall, MD and Rachel K. Jackson In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1086-1094. doi: 10.1001/journalofethics.2016.18.11.ecas3-1611. Case and Commentary Jan 2009 Outpatient Commitment: A Treatment Tool for the Mentally Ill? Commentary 2 Ann Hackman, MD Benefits and risks of outpatient commitment are a means for managing mental illness in patients who are homeless. Virtual Mentor. 2009;11(1):9-12. doi: 10.1001/virtualmentor.2009.11.1.ccas1-0901. Case and Commentary Jan 2009 Outpatient Commitment: A Treatment Tool for the Mentally Ill? Commentary 1 Scott C. Fears, MD, PhD Benefits and risks of outpatient commitment are a means for managing mental illness in patients who are homeless. Virtual Mentor. 2009;11(1):6-9. doi: 10.1001/virtualmentor.2009.11.1.ccas1-0901.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Case and Commentary Nov 2016 Should Mental Health Screening and Psychotherapy Be Required Prior to Body Modification for Gender Expression? Timothy F. Murphy, PhD Although patients’ medical gender transition can be facilitated by counseling, as a matter of medical ethics, informed consent must be obtained for treatment. AMA J Ethics. 2016;18(11):1079-1085. doi: 10.1001/journalofethics.2016.18.11.ecas2-1611.
Case and Commentary Nov 2016 Should Psychiatrists Prescribe Gender-Affirming Hormone Therapy to Transgender Adolescents? Cary S. Crall, MD and Rachel K. Jackson In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1086-1094. doi: 10.1001/journalofethics.2016.18.11.ecas3-1611.
Case and Commentary Jan 2009 Outpatient Commitment: A Treatment Tool for the Mentally Ill? Commentary 2 Ann Hackman, MD Benefits and risks of outpatient commitment are a means for managing mental illness in patients who are homeless. Virtual Mentor. 2009;11(1):9-12. doi: 10.1001/virtualmentor.2009.11.1.ccas1-0901.
Case and Commentary Jan 2009 Outpatient Commitment: A Treatment Tool for the Mentally Ill? Commentary 1 Scott C. Fears, MD, PhD Benefits and risks of outpatient commitment are a means for managing mental illness in patients who are homeless. Virtual Mentor. 2009;11(1):6-9. doi: 10.1001/virtualmentor.2009.11.1.ccas1-0901.